The EORTC and the BioMed Alliance, together with MEP Maria da Graça Carvalho and MEP Dolors Montserrat, will organise an interactive webinar on 3 February 2021 from 15:00-17:00 CET on the issue of treatment optimisation.
The online event will bring together important health stakeholders and policy makers with the purpose to analyse how the current policy initiatives can facilitate treatment optimisation studies in the health systems across Europe. The 2-hour webinar aims to explore how treatment optimisation can be facilitated to ensure the most effective, efficient, safe and proportionate treatment adapted to patients’ needs.
Recent health threats such as COVID-19 demonstrated the urgent need for a healthcare system that places the patient at the centre and has the ultimate goal to solve clinical issues. This is distinct from the currently dominant drug-driven approach in treatment development in oncology and in other medical specialities, which tends to neglect important aspects of the use of novel therapies in real-world settings. Clinical research questions such as optimal dose, duration, sequence, combination, and quality of life do not get the attention they deserve. With a patient-centric approach, by contrast, new drugs reaching the market is not an end, but just a start, with studies of treatment optimisation then improving the utilisation of treatments in real-world conditions.
The discussion is timely considering the current health challenges and the preparation of the ambitious European Health Union programme and its policy and legislative measures such as the Pharmaceutical Strategy, the upcoming Horizon Europe, the EU4Health programme, and Europe’s Beating Cancer Plan.
You can register to the event here.